SEARCH

SEARCH BY CITATION

References

  • ABBOTT, C.R., ROSSI, M., KIM, M., ALAHMED, S.H., TAYLOR, G.M., GHATEI, M.A., SMITH, D.M. & BLOOM, S.R. (2000). Investigation of the melanocyte stimulating hormones on food intake. Lack of evidence to support a role for the melanocortin-3 receptor. Brain Res., 869, 203210.
  • BHOGAL, R., SMITH, D.M., PURKISS, P. & BLOOM, S.R. (1993). Molecular identification of binding sites for calcitonin gene-related peptide (CGRP) and islet amyloid polypeptide (IAPP) in mammalian lung: species variation and binding of truncated CGRP and IAPP. Endocrinology, 133, 23512361.
  • BRAIN, S.D. & CAMBRIDGE, H. (1996). Calcitonin gene-related peptide: vasoactive effects and potential therapeutic role. Gen. Pharmacol., 27, 607611.
  • BUHLMANN, N., LEUTHAUSER, K., MUFF, R., FISCHER, J.A. & BORN, W. (1999). A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1. Endocrinology, 140, 28832890.
  • CARON, K.M. & SMITHIES, O. (2001). Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene. Proc. Natl. Acad. Sci., 98, 615619.
  • CHAKRAVARTY, P., SUTHAR, T.P., COPPOCK, H.A., NICHOLL, C.G., BLOOM, S.R., LEGON, S. & SMITH, D.M. (2000). CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues. Br. J. Pharmacol., 130, 189195.
  • CHIBA, T., YAMAGUCHI, A., YAMATANI, T., NAKAMURA, A., MORISHITA, T., INUI, T., FUKASE, M., NODA, T. & FUJITA, T. (1989). Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am. J. Physiol., 256, E331E335.
  • COPPOCK, H.A., OWJI, A.A., AUSTIN, C., UPTON, P.D., JACKSON, M.L., GARDINER, J.V., GHATEI, M.A., BLOOM, S.R. & SMITH, D.M. (1999). Rat-2 fibroblasts express specific adrenomedullin receptors, but not calcitonin-gene-related-peptide receptors, which mediate increased intracellular cAMP and inhibit mitogen-activated protein kinase activity. Biochem. J., 338, 1522.
  • COPPOCK, H.A., OWJI, A.A., BLOOM, S.R. & SMITH, D.M. (1996). A rat skeletal muscle cell line (L6) expresses specific adrenomedullin binding sites but activates adenylate cyclase via calcitonin gene-related peptide receptors. Biochem. J., 318, 241245.
  • COX, H.M. & TOUGH, I.R. (1994). Calcitonin gene-related peptide receptors in human gastrointestinal epithelia. Br. J. Pharmacol., 113, 12431248.
  • DENNIS, T., FOURNIER, A., CADIEUX, A., POMERLEAU, F., JOLICOEUR, F.B., ST. PIERRE, S. & QUIRION, R. (1990). hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J. Pharmacol. Exp. Ther., 254, 123128.
  • DENNIS, T., FOURNIER, A., ST. PIERRE, S. & QUIRION, R. (1989). Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J. Pharmacol. Exp. Ther., 251, 718725.
  • DOODS, H. (2001). Development of CGRP antagonists for the treatment of migraine. Curr. Opin. Investig. Drugs, 2, 12611268.
  • DUMONT, Y., FOURNIER, A., ST. PIERRE, S. & QUIRION, R. (1997). A potent and selective CGRP2 agonist, [Cys(Et)2,7]hCGRP alpha: comparison in prototypical CGRP1 and CGRP2 in vitro bioassays. Can. J. Physiol. Pharmacol., 75, 671676.
  • EDVINSSON, L. (2001). Aspects on the pathophysiology of migraine and cluster headache. Pharmacol. Tox., 89, 6573.
  • FINDLAY, D.M., HOUSSAMI, S., LIN, H.Y., MYERS, D.E., BRADY, C.L., DARCY, P.K., IKEDA, K., MARTIN, T.J. & SEXTON, P.M. (1994). Truncation of the porcine calcitonin receptor cytoplasmic tail inhibits internalization and signal transduction but increases receptor affinity. Mol. Endocrinol., 8, 16911700.
  • FLUHMANN, B., MUFF, R., HUNZIKER, W., FISCHER, R.A. & BON, W. (1995). A human orphan calcitonin receptor-like structure. Biochem. Biophys. Res, Commun., 206, 341347.
  • HAGNER, S., HABERBERGER, R., KUMMER, W., SPRINGER, J., FISCHER, A., BOHM, S., GOKE, B. & MCGREGOR, G.P. (2001). Immunohistochemical detection of calcitonin gene-related peptide receptor (CGRPR-1) in the endothelium of human coronary artery and bronchial blood vessels. Neuropeptides, 35, 17.
  • HAN, Z.Q., COPPOCK, H.A., SMITH, D.M., VAN NOORDEN, S., MAKGOBA, M.W., NICHOLL, C.G. & LEGON, S. (1997). The interaction of CGRP and adrenomedullin with a receptor expressed in the rat pulmonary vascular endothelium. J. Mol. Endocrinol., 18, 267272.
  • HAY, D.L. & SMITH, D.M. (2001). Knockouts and transgenics confirm the importance of adrenomedullin in the vasculature. Trends Pharmacol. Sci., 22, 5759.
  • HENKE, H., SIGRIST, S., LANG, W., SCHNEIDER, J. & FISCHER, J.A. (1987). Comparison of binding sites for the calcitonin gene-related peptides I and II in man. Brain Res., 410, 404408.
  • HILAIRET, S., FOORD, S.M., MARSHALL, F.H. & BOUVIER, M. (2001). Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins. J. Biol. Chem., 31, 2957529581.
  • HINSON, J.P., KAPAS, S. & SMITH, D.M. (2000). Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev., 21, 138167.
  • KAMITANI, S., ASAKAWA, M., SHIMEKAKE, Y., KUWASAKO, K., NAKAHARA, K. & SAKATA, T. (1999). The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells. FEBS Lett., 448, 111114.
  • KAPAS, S., CATT, K.J. & CLARK, A.J. (1995). Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J. Biol. Chem., 270, 2534425347.
  • KAPAS, S. & CLARK, A.J. (1995). Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor. Biochem. Biophys. Res. Commun., 217, 832838.
  • KENNEDY, S.P., SUN, D., OLEYNEK, J.J., HOTH, C.F., KONG, J. & HILL, R.J. (1998). Expression of the rat adrenomedullin receptor or a putative human adrenomedullin receptor does not correlate with adrenomedullin binding or functional response. Biochem. Biophys. Res. Commun., 244, 832837.
  • KIRKLAND, S.C. (1985). Dome formation by a human colonic adenocarcinoma cell line (HCA-7). Cancer Res., 45, 37903795.
  • LIN, H.Y., HARRIS, T.L., FLANNERY, M.S., ARUFFO, A., KAJI, E.H., GORN, A., KOLAKOWSKILF, J., LODISH, H.F. & GOLDRING, S.R. (1991). Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science, 254, 10221024.
  • LONGMORE, J., HOGG, J.E., HUTSON, P.H. & HILL, R.G. (1994). Effects of two truncated forms of human calcitonin-gene related peptide: implications for receptor classification. Eur. J. Pharmacol., 265, 5359.
  • MCLATCHIE, L.M., FRASER, N.J., MAIN, M.J., WISE, A., BROWN, J., THOMPSON, N., SOLARI, R., LEE, M.G. & FOORD, S.M. (1998). RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature, 33, 333339.
  • MAKINO, I., HONDA, K., MAKINO, Y., OKANO, I., KANGAWA, K., KAMIYAHO, H.O., SHIBATA, K. & KAWARABAYASHI, T. (2001). Phenotypic changes of adrenomedullin receptor components, RAMP2 and CRLR mRNA expression in cultured rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 258, 515520.
  • MORGAN, D.G., KULKARNI, R.N.,. HURLEY, J.D., WANG, Z.L., WANG, R.M., GHATEI, M.A., KARLSEN, A.E., BLOOM, S.R. & SMITH, D.M. (1998). Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells. Diabetologia, 41, 14821491.
  • MUFF, R., BUHLMANN, N., FISCHER, J.A. & BORN, W. (1999). An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3. Endocrinology, 140, 29242927.
  • MUFF, R., LEUTHAUSER, K., BUHLMANN, N., FOORD, S.M., FISCHER, J.A. & BORN, W. (1998). Receptor activity modifying proteins regulate the activity of a calcitonin gene-related peptide receptor in rabbit aortic endothelial cells. FEBS Lett., 441, 366368.
  • NIKITENKO, L.L., BROWN, N.S., SMITH, D.M., MACKENZIE, I.Z., BICKNELL, R. & RESS, M.C.P. (2001). Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus. Mol. Human Reproduction, 7, 655664.
  • NJUKI, F., NICHOLL, C.G., HOWARD, A., MAK, J.C., BARNES, P.J., GIRGIS, S.I. & LEGON, S. (1993). A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. Clin. Sci. Colch., 85, 385388.
  • OLIVER, K.R., KANE, S.A., SALVATORE, C.A., MALLEE, J.J., KINSEY, A.M., KOBLAN, K.S., KEYVAN-FOULADI, N., HEAVENS, R.P., WAINWRIGHT, A., JACOBSON, M., DICKERSON, I.M. & HILL, R.G. (2001). Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat. Eur. J. Neuroscience, 14, 618628.
  • OWJI, A.A., SMITH, D.M., COPPOCK, H.A., MORGAN, D.G., BHOGAL, R., GHATEI, M.A. & BLOOM, S.R. (1995). An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology, 136, 21272134.
  • POYNER, D.R., ANDREW, D.P., BROWN, D., BOSE, C. & HANLEY, M.R. (1992). Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes. Br. J. Pharmacol., 105, 441447.
  • POYNER, D.R., SEXTON, P.M., MARSHALL, I., SMITH, D.M., QUIRION, R., BORN, W., MUFF, R., FISCHER, J.A. & FOORD, S.M. (2002). International Union of Pharmacology. The mammalian CGRP, adrenomedullin, amylin and calcitonin receptors. Pharmacol Rev., 54, 114.
  • POYNER, D.R., SOOMETS, U., HOWITT, S.G. & LANGEL, U. (1998). Structural determinants for binding to CGRP receptors expressed by human SK-N-MC and Col-29 cells: studies with chimeric and other peptides. Br. J. Pharmacol., 124, 16591666.
  • RORABAUGH, B.R., SCOFIELD, M.A., SMITH, D.D., JEFFRIES, W.B. & ABEL, P.W. (2001). Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction. J. Pharmacol. Exp. Ther., 299, 10861094.
  • SEXTON, P.M., MCKENZIE, J.S., MASON, R.T., MOSELEY, J.M., MARTIN, T.J. & MENDELSOHN, F.A. (1986). Localization of binding sites for calcitonin gene-related peptide in rat brain by in vitro autoradiography. Neuroscience, 19, 12351245.
  • SHARMA, S.K., AUSTIN, C., HOWARD, A., LO, G., NICHOLL, C.G. & LEGON, S. (1992). Characterization of rat gastric inhibitory peptide cDNA. J. Mol. Endocrinol., 9, 265272.
  • SULISTIYANI & ST. CLAIR, R.W. (1991). The method of isolation of primary cells and their subculture influences the expression of LDL receptors on pigeon and chick embryo cells in culture. Atherosclerosis, 91, 123135.
  • TILAKARATNE, N., CHRISTOPOULOS, G., ZUMPE, E.T., FOORD, S.M. & SEXTON, P.M. (2000). Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment. J. Pharmacol. Exp. Ther., 294, 6172.
  • UEDA, T., UGAWA, S., SAISHIN, Y. & SHIMADA, S. (2001). Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain. Mol. Brain Res., 93, 3645.
  • UPTON, P.D., AUSTIN, C., TAYLOR, G.M., NANDHA, K.A., CLARK, A.J., GHATEI, M.A., BLOOM, S.R. & SMITH, D.M. (1997). Expression of adrenomedullin (ADM) and its binding sites in the rat uterus: increased numbers of binding sites and ADM messenger ribonucleic acid in 20-day old pregnant rats compared with non pregnant rats. Endocrinology, 138, 25082514.
  • WISSKIRCHEN, F.M., BURT, R.P. & MARSHALL, I. (1998). Pharmacological characterization of CGRP receptors mediating relaxation of the rat pulmonary artery and inhibition of twitch responses of the rat vas deferens. Br. J. Pharmacol., 123, 16731683.
  • WU, D., EBERLEIN, W., RUDOLF, K., ENGEL, W., HALLERMAYER, G. & DOODS, H. (2000). Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2,7)]hCGRP-preferring receptor. Eur. J. Pharmacol., 400, 313319.